(ULS) UL Solutions - Overview
Sector: Industrials | Industry: Specialty Business Services | Exchange: NYSE (USA) | Market Cap: 20.070m USD | Total Return: 41.4% in 12m
Avg Turnover: 66.4M
Qual. Beats: 3
Rev. Trend: 99.9%
Qual. Beats: 0
Warnings
Below Avwap Earnings
Tailwinds
Supp Ema20
UL Solutions Inc. (ULS) is a global provider of testing, inspection, and certification (TIC) services. Founded in 1894 and headquartered in Northbrook, Illinois, the company operates through three primary segments: Industrial, Consumer, and Software and Advisory. Its core business involves verifying product safety, performance, and regulatory compliance across diverse sectors, including energy, medical devices, and consumer electronics.
The TIC industry operates on a recurring revenue model driven by mandatory regulatory standards and the continuous introduction of new technologies. ULS specifically integrates software solutions, such as its ULTRUS platform, to help clients manage supply chain transparency and sustainability reporting. This integration of digital advisory services reflects a broader sector shift toward automating compliance workflows.
For a detailed breakdown of the companys financial health and valuation metrics, consider reviewing the latest data on ValueRay. This legacy organization serves as a critical intermediary between manufacturers and global regulators, facilitating market access for complex technologies like 5G and industrial automation.
- Renewed industrial electrification and automation demand drives testing and certification revenue
- Expansion of the ULTRUS software platform improves high-margin recurring revenue streams
- Increasing global regulatory complexity accelerates demand for compliance and advisory services
- Consumer electronics lifecycle shifts and 5G adoption influence testing volume growth
- Global supply chain transparency requirements boost demand for sustainability and risk software
| Net Income: 349.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.15 > 0.02 and ΔFCF/TA 4.60 > 1.0 |
| NWC/Revenue: 4.76% < 20% (prev 6.68%; Δ -1.91% < -1%) |
| CFO/TA 0.23 > 3% & CFO 665.0m > Net Income 349.0m |
| Net Debt (463.0m) to EBITDA (772.4m): 0.60 < 3 |
| Current Ratio: 1.16 > 1.5 & < 3 |
| Outstanding Shares: last quarter (204.0m) vs 12m ago 0.49% < -2% |
| Gross Margin: 49.61% > 18% (prev 0.49%; Δ 4.91k% > 0.5%) |
| Asset Turnover: 106.5% > 50% (prev 100.9%; Δ 5.56% > 0%) |
| Interest Coverage Ratio: 14.45 > 6 (EBITDA TTM 772.4m / Interest Expense TTM 37.0m) |
| A: 0.05 (Total Current Assets 1.05b - Total Current Liabilities 899.0m) / Total Assets 2.96b |
| B: 0.18 (Retained Earnings 533.0m / Total Assets 2.96b) |
| C: 0.18 (EBIT TTM 534.7m / Avg Total Assets 2.92b) |
| D: 0.33 (Book Value of Equity 533.0m / Total Liabilities 1.62b) |
| Altman-Z'' = 2.49 = A |
| DSRI: 0.70 (Receivables 497.0m/666.0m, Revenue 3.11b/2.90b) |
| GMI: 0.98 (GM 49.61% / 48.61%) |
| AQI: 0.93 (AQ_t 0.35 / AQ_t-1 0.37) |
| SGI: 1.07 (Revenue 3.11b / 2.90b) |
| TATA: -0.11 (NI 349.0m - CFO 665.0m) / TA 2.96b) |
| Beneish M = -3.39 (Cap -4..+1) = AA |
As of May 30, 2026, the stock is trading at USD 99.50 with a total of 722,079 shares traded.
Over the past week, the price has changed by -2.63%,
over one month by +13.22%,
over three months by +18.87% and
over the past year by +41.36%.
UL Solutions has received a consensus analysts rating of 3.82. Therefore, it is recommended to buy ULS.
- StrongBuy: 4
- Buy: 2
- Hold: 4
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 109 | 9.5% |
P/E Trailing = 57.8895
P/E Forward = 42.3729
P/S = 6.4616
P/B = 15.2158
P/EG = 2.2658
Revenue TTM = 3.11b USD
EBIT TTM = 534.7m USD
EBITDA TTM = 772.4m USD
Long Term Debt = 357.0m USD (from longTermDebt, last quarter)
Short Term Debt = 41.0m USD (from shortTermDebt, last quarter)
Debt = 721.0m USD (from shortLongTermDebtTotal, last quarter) + Leases 182.0m
Net Debt = 463.0m USD (calculated: Debt 721.0m - CCE 258.0m)
Enterprise Value = 20.5b USD (20.1b + Debt 721.0m - CCE 258.0m)
Interest Coverage Ratio = 14.45 (Ebit TTM 534.7m / Interest Expense TTM 37.0m)
EV/FCF = 45.63x (Enterprise Value 20.5b / FCF TTM 450.0m)
FCF Yield = 2.19% (FCF TTM 450.0m / Enterprise Value 20.5b)
FCF Margin = 14.49% (FCF TTM 450.0m / Revenue TTM 3.11b)
Net Margin = 11.24% (Net Income TTM 349.0m / Revenue TTM 3.11b)
Gross Margin = 49.61% ((Revenue TTM 3.11b - Cost of Revenue TTM 1.57b) / Revenue TTM)
Gross Margin QoQ = 50.26% (prev 48.90%)
Tobins Q-Ratio = 6.95 (Enterprise Value 20.5b / Total Assets 2.96b)
Interest Expense / Debt = 5.13% (Interest Expense 37.0m / Debt 721.0m)
Taxrate = 24.81% (32.0m / 129.0m)
NOPAT = 402.1m (EBIT 534.7m * (1 - 24.81%))
Current Ratio = 1.16 (Total Current Assets 1.05b / Total Current Liabilities 899.0m)
Debt / Equity = 0.54 (Debt 721.0m / totalStockholderEquity, last quarter 1.34b)
Debt / EBITDA = 0.60 (Net Debt 463.0m / EBITDA 772.4m)
Debt / FCF = 1.03 (Net Debt 463.0m / FCF TTM 450.0m)
Total Stockholder Equity = 1.23b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.97% (Net Income 349.0m / Total Assets 2.96b)
RoE = 28.40% (Net Income TTM 349.0m / Total Stockholder Equity 1.23b)
RoCE = 33.71% (EBIT 534.7m / Capital Employed (Equity 1.23b + L.T.Debt 357.0m))
RoIC = 21.09% (NOPAT 402.1m / Invested Capital 1.91b)
WACC = 8.58% (E(20.1b)/V(20.8b) * Re(8.75%) + D(721.0m)/V(20.8b) * Rd(5.13%) * (1-Tc(0.25)))
Discount Rate = 8.75% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 95.45 | Cagr: 0.88%
[DCF] Terminal Value 77.23% ; FCFF base≈392.4m ; Y1≈449.8m ; Y5≈662.0m
[DCF] Fair Price = 117.1 (EV 9.57b - Net Debt 463.0m = Equity 9.11b / Shares 77.8m; r=8.58% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 1.84 | # QB: 3
Revenue Correlation: 99.92 | Revenue CAGR: 6.99% | SUE: 0.57 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.56 | Chg30d=+2.32% | Revisions=+14% | Analysts=9
EPS next Quarter (2026-09-30): EPS=0.62 | Chg30d=+1.52% | Revisions=-25% | Analysts=9
EPS current Year (2026-12-31): EPS=2.30 | Chg30d=+5.07% | Revisions=+64% | GrowthEPS=+15.8% | GrowthRev=+5.4%
EPS next Year (2027-12-31): EPS=2.58 | Chg30d=+4.18% | Revisions=+56% | GrowthEPS=+11.9% | GrowthRev=+7.1%
[Analyst] Revisions Ratio: +64%